/Investor DB

BioBrit — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

DelNovadelnova.netinMar 2018

DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing.

BiotechHealthtechMedical DevicesHighland, US

Mary Gardner(Chief Executive Officer & Founder)inSameer B. Shah(Chief Scientist)Steven Yoelin(Chief Medical Strategist)Dimas Jimenez(Chief Financial Advisor)

BoardDaniel Bradbury(Director)in

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.